Literature DB >> 33456188

Turner syndrome and autosomal dominant polycystic kidney disease.

Rachel Styer1, Matthew Stephen2, Faris Hashim3, Krista Birkemeier4.   

Abstract

Turner syndrome is a chromosomal disorder that involves multiple organ systems and is typically associated with short stature. A multidisciplinary approach with regular screening and surveillance is key to managing this condition's multiple comorbidities. We present a case of a young girl with Turner syndrome and associated short stature on growth hormone treatment who presented with cystic renal disease found to be autosomal dominant kidney disease. We propose reevaluation of renal screening guidelines in this population due to the potential association of growth hormone and cyst proliferation.
Copyright © 2020 Baylor University Medical Center.

Entities:  

Keywords:  Growth hormone; PKD1 mutation; Turner syndrome; polycystic kidney disease

Year:  2020        PMID: 33456188      PMCID: PMC7785201          DOI: 10.1080/08998280.2020.1838182

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  12 in total

1.  Guidelines on the management of renal cyst disease.

Authors:  Thomas F Whelan
Journal:  Can Urol Assoc J       Date:  2010-04       Impact factor: 1.862

Review 2.  Autosomal dominant polycystic kidney disease.

Authors:  Vicente E Torres; Peter C Harris; Yves Pirson
Journal:  Lancet       Date:  2007-04-14       Impact factor: 79.321

3.  Hyperproliferation of PKD1 cystic cells is induced by insulin-like growth factor-1 activation of the Ras/Raf signalling system.

Authors:  E Parker; L J Newby; C C Sharpe; S Rossetti; A J Streets; P C Harris; M J O'Hare; A C M Ong
Journal:  Kidney Int       Date:  2007-03-28       Impact factor: 10.612

4.  The kidney in acromegaly: renal structure and function in patients with acromegaly during active disease and 1 year after disease remission.

Authors:  Renata S Auriemma; Mariano Galdiero; Maria C De Martino; Monica De Leo; Ludovica F S Grasso; Pasquale Vitale; Alessia Cozzolino; Gaetano Lombardi; Annamaria Colao; Rosario Pivonello
Journal:  Eur J Endocrinol       Date:  2010-03-31       Impact factor: 6.664

Review 5.  Autosomal dominant polycystic kidney disease in children.

Authors:  Melissa A Cadnapaphornchai
Journal:  Curr Opin Pediatr       Date:  2015-04       Impact factor: 2.856

Review 6.  Turner syndrome: mechanisms and management.

Authors:  Claus H Gravholt; Mette H Viuff; Sara Brun; Kirstine Stochholm; Niels H Andersen
Journal:  Nat Rev Endocrinol       Date:  2019-06-18       Impact factor: 43.330

Review 7.  Impact of growth hormone hypersecretion on the adult human kidney.

Authors:  Solange Grunenwald; Ivan Tack; Dominique Chauveau; Antoine Bennet; Philippe Caron
Journal:  Ann Endocrinol (Paris)       Date:  2011-11-17       Impact factor: 2.478

Review 8.  Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting.

Authors:  Claus H Gravholt; Niels H Andersen; Gerard S Conway; Olaf M Dekkers; Mitchell E Geffner; Karen O Klein; Angela E Lin; Nelly Mauras; Charmian A Quigley; Karen Rubin; David E Sandberg; Theo C J Sas; Michael Silberbach; Viveca Söderström-Anttila; Kirstine Stochholm; Janielle A van Alfen-van derVelden; Joachim Woelfle; Philippe F Backeljauw
Journal:  Eur J Endocrinol       Date:  2017-09       Impact factor: 6.664

Review 9.  Growth hormone, insulin-like growth factor-1, and the kidney: pathophysiological and clinical implications.

Authors:  Peter Kamenický; Gherardo Mazziotti; Marc Lombès; Andrea Giustina; Philippe Chanson
Journal:  Endocr Rev       Date:  2013-12-20       Impact factor: 19.871

10.  Renal cysts associated with Turner's syndrome.

Authors:  T E Herman; M J Siegel
Journal:  Pediatr Radiol       Date:  1994
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.